Comparative assessment of bronchial asthma control level in patients aged 12 to 17 years old of EsSalud Arequipa
DOI:
https://doi.org/10.24265/horizmed.2017.v17n2.04Keywords:
Asthma, ACT, Asthma programAbstract
Objective: This was an observational, cross-sectional and prospective study to compare the bronchial asthma control level in pediatric patients aged 12 to 17 years old who take part in the Hospital III Yanahuara – EsSalud Arequipa’s Asthma Program and have the same control level achieved in other EsSalud Arequipa’s health care centers, according to the internationally validated instrument named “Asthma Control Test” (ACT). Materials and methods: A sample was taken from 60 patients distributed into two groups: one of them consisted of 30 patients who took part in the Hospital Yanahuara Pediatric Unit’s Asthma Program and the other one of 30 outpatients from other EsSalud’s pediatric health care centers. For the purpose of the analysis, proportionality was maintained with regard to gender and asthma severity in both groups. Results: The average ACT score was 22.27 in the group who took part in the Hospital III Yanahuara’s Asthma Program and 20.17 in the group of outpatients who went to other pediatric health care centers. The most frequent score was 25 for the first group and 23 for the second one. More than half of the patients from both groups achieved an acceptable score in the disease control test. Nevertheless, “total control” was mainly achieved by patients who took part in a preventive program (26.67% versus 6.67%) and “poor control” was mainly observed in children assessed in a pediatric outpatient consultation (36.66% versus 16.66%). Conclusions: The vast majority of children who take part in an asthma control preventive program achieve a total or acceptable asthma control with a statistically significant difference.
Downloads
References
Global Initiative for Asthma (GINA), guía de bolsillo para el manejo y la prevención del asma. 2016; 1 – 35.
Guía Española para el manejo del Asma (GEMA). Comité Ejecutivo de la GEMA. 2015; 1 – 164.
Mallol J, Solé D, Asher I, Stein R, Soto-Quiroz M. Prevalence of asthma symptoms in Latin America: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Pulmonol. 2000; 30(6): 439 – 444.
Akimbami L, Simon A, Rossen L. Changing trends in asthma prevalence among children. Pediatrics. 2016; 137(1):2015- 354
Forno E, Gogna M, Cepeda A, Yáñez A, Solé D, Cooper P, et al. Asthma in Latin America. Thorax. 2015; 70 (9): 898 – 905.
Recabarren A, Cusirramos D, Gutiérrez V, Andrade P, Chiarella P. Prevalencia y severidad del asma bronquial en niños de 13 – 14 años de la ciudad de Arequipa y su variación en 12 años (1996 – 2008). Neumología Pediátrica 2010; 5(Supl 1): 32.
Guía de práctica clínica sobre asma infantil. Ministerio de Sanidad, servicios sociales e igualdad. Gobierno Vasco. 2015; 1 – 162.
Gobierno de Chile: Guía clínica AUGE, Asma bronquial moderada y grave en menores de 15 años. Serie guías clínicas MINSAL. 2011; 1 – 48.
Giubergia V, Balanzat A, Teper A, Vidaurreta S. Guía de diagnóstico y tratamiento: asma bronquiial en niños > 5 años. Arch Argen Pediatr. 2016; 114 (6): 595 – 6
Gobierno Federal de México: Diagnóstico y tratamiento del asma en menores de 18 años de edad. Guía de práctica clínica GPC. 2013; 1 – 20.
Carvalho C, Baldi B, Viana C, Caruso P. Diretrizes da Sociedade Brasileira de Pneumología e Tisiología para o Manejo da Asma. Jornal Brasileiro de Pneumologia. 2012; 38(supl1):1 – 46.
Rodrigo G, Plaza V, Bardagi S, Castro-Rodríguez J, Damiá A, Liña S, et al. ALAT Guía Alerta 2. América Latina y España: Recomendaciones para la prevención y el tratamiento de la exacerbación asmática. Arch Bronconeumol. 2010; 46 (Supl 7): 1 – 20.
Boulet L, Boulet V, Milot J. How should we quantify asthma control ? Chest. 2002; 122(6): 2217 – 23.
Bateman E, Boushey H, Bousquet J, Busse W, Clark T, Pauwels R, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med. 2004; 170(8): 836 – 44.
Nathan R, Sorkness C, Kosinski M, Schatz M. Development of the asthma control test: a survey for assessing asthma control. J All Clin Inmunol 2004;113(1):59– 65.
Fuhlbrigge A, Adams R, Guilbert T, Grant E, Lozano P, Janson P, et al. The burden of asthma in the United States: level and distribution are dependent on interpretation of the National asthma education and prevention program guidelines. Am J Respir Crit Care Med 2002; 166(8): 1044 – 9.
Recabarren A, Apaza C, Castro-Rodríguez J. Nitrites in induced sputum as a simple and cheap non-invasive marker of airway inflammation for asthmatic schoolchildren. Pediatr Allergy Immunol. 2008; 19(5): 433 – 7.
Brouwer A, Roorda R, Brand P. Comparison between Peak Expiratory Flow and FEV1 measurements on a home spirometer and on a pneumotachograph in children with asthma. Pediatr Pulmonol. 2007; 42(9): 813 – 8.
Lazo-Velásquez J, Lozada A, Cruz H. Evaluation of severity of bronchial asthma through an exercise bronchial challenge. Pediatr Pulmonol. 2005; 40(5):457– 63.
Beerthuizen T, Voored-van S, van den Hout W, VaessenVerberne A, Brackel H, Landstra A, et al. Cost-effectiveness of FENO-based and web-based monitoring in paediatric asthma management: a randomised controlled trial. Thorax. 2016; 71(7): 607 – 13.
Voorend-van Bergen, Vaessen V, Jongste JC, Pijnemburg M. Asthma control questionnaires in the management of asthma in children: a review. Ped Pulmonol 2015; 50(2): 202–8.
Oliveira S, Sarria E, Roncada C, Stein R, Pitrez M, Matiello R. Validation of the Brazilian version of the childhood asthma control test (ACT). Ped Pulmonol. 2016; 51(4): 358 – 63.
Bussi L, Sly P, Restuccia S, LLancamán L. Validation of a schoolbased written questionnaire for asthma case identification in Argentina. Ped Pulmonol. 2012; 47(1): 1 – 7.
Castro-Rodríguez J, Molina R, Cáceres M, Recabarren A. Correlation between Nitrites in induced sputum and asthma symptoms in asthmatic schoolchildren. Ped Pulmonol. 2014; 49(3): 214 – 20.
Chinellato I, Piazza M, Sandri M, Cardinali F, Peroni G, Boner A, et al. Evaluation of association between exercise-induced bronchoconstriction and childhood asthma control test (ACT) questionnaire scores in children. Pediatr Pulmono.l 2012; 47(3): 226 – 32.
Pedersen S, Hurd S, Lemanske R, Becker A, Zar H, Sly P, et al. Global strategy for the diagnosis and mangement of asthma in children 5 years and younger. Pediatr Pulmonol. 2011; 46(1): 1 – 17.
Koolen B, Pignenburg M, Brackel H, Landstra A, Van den Bergh N, Merkus P, et al. Validation of a web-based versión of the asthma control test and chidhood asthma control test. Pediatr Pulmonol. 2011; 46(10): 941 – 8.
Murray C, Foden P, Sumner H, Shepley E, Custovic A, Simpson A. Preventing severe asthma exacerbations in children: a randomised trial of mite impermeable bedcovers. American Journal Respir Critical Care Medicine. 2017
Farber H, Batsell R, Silveira E, Calhoun R, Giardino A. The impact of tobacco smoke exposure on childhood asthma in a Medicaid managed Care Plan.Chest 2016; 149 (3): 721 – 8.
Chen C, Chao H, Chang C, Chen B, Guo Y. Current asthma in schoolchildren is related to fungal spores in classrooms. Chest. 2014; 146(1): 123 – 34.
Barrat B, Quint J. Asthma hospitalizations and air pollution. Thorax. 2016; 71(12): 1076 – 7.
Recabarren A, Portugal K, Gutiérrez J. Comparación de las características clínicas del asma bronquial entre niños con sobrepeso/obesidad y niños eutróficos inscritos en el programa de asma bronquial del Hospital III Yanahuara – EsSalud Arequipa. Diagnóstico 2003; 42(2): 60 – 7.
Bitsko M, Everhart R, Rubin B. The adolescent with asthma. Paediatr Respir Rev. 2013; 15(2): 146 – 53.
Jensen M, Collins C, Gibson P, Wood L. The obesity phenotype in children with asthma. Paediatr Respir Rev. 2011; 12(3): 152 – 9.
Shefer G, Donchin M, Manor O, Levy-Hervroni R, Schechter A, Cohen H, et al. Disparities in assesments of asthma control between children, parents and physicians. Pediatr Pulmonol. 2014; 49(10): 943 – 51.
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
